PDL BioPharma

PDLI-Q

NASDAQ:PDLI

2.95
0.04 (1.34%)
PDL BioPharma is a publicly traded American holding company that since 2008 manages patents and other intellectual property that had been generated by the company.
More at Wikipedia

Analysis and Opinions about PDLI-Q

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
July 12, 2006
Higher valuation stocks are going to have a tougher time when people are concerned about a slowing economy. This one has been weakening since March. There is no sign of any real bounce on the little bit of recent strength.
Higher valuation stocks are going to have a tougher time when people are concerned about a slowing economy. This one has been weakening since March. There is no sign of any real bounce on the little bit of recent strength.
David Burrows
President & Chief Investment Strategist, Barometer Capital Management
Price
$17.800
Owned
No
TOP PICK
TOP PICK
February 27, 2006
Company is developing compounds which won't harm the body but will help. Multi-billion dollar business. He has owned it for about 3 months and continues to buy.
PDL BioPharma (PDLI-Q)
February 27, 2006
Company is developing compounds which won't harm the body but will help. Multi-billion dollar business. He has owned it for about 3 months and continues to buy.
David Burrows
President & Chief Investment Strategist, Barometer Capital Management
Price
$30.550
Owned
Yes
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »